Company Summary
Vertero is a scientific leader in the biological role of the microbiome-gut-brain axis and its influence on the central nervous system. Harnessing its unique expertise in the microbiome, Vertero Therapeutics, formally known as Axial Therapeutics, is developing small molecule drugs with defined mechanisms of action with new targets to mitigate the impact of metabolites and gut bacteria linked to neurological disorders and disease pathology, progression, and symptoms.